fbpx

How masculinity can affect men’s health behaviours with MS

How masculinity can affect men’s health behaviours with MSPublished: 17 August 2022 Male multiple sclerosis (MS) patients display different health-related behaviour depending on which masculine ideals they value, according to a new study. MS in men is less common – the condition affects women almost three times more than men,
Read More

Heart medication helps with remyelination in mouse study

Heart medication helps with remyelination in mouse studyPublished: 16 August 2022 Digoxin, a prescription-only drug for heart problems, has been found to promote myelin repair in a mouse model of multiple sclerosis (MS). Most drugs for MS modulate the immune system to try and control inflammation, but there is yet
Read More

Stem cell treatment failed to reduce inflammation in MS

Stem cell treatment failed to reduce inflammation in MS Published: 28 October 2021 Treatment with mesenchymal stem cells (MSCs) has failed to significantly reduce inflammation in the brain of adults with multiple sclerosis (MS) in a phase 2 clinical trial. The into-the-vein treatment also failed to improve other clinical aspects
Read More

America green lights new stem cell trial for MS

America green lights new stem cell trial for MS Published: 28 July 2021 A Phase 2 clinical trial to assess the efficacy of using mesenchymal stem cells (MSCs) to treat mild to moderate multiple sclerosis (MS) will go ahead in the US after the Food and Drug Administration (FDA) gave
Read More

Biotin fails to help MS in latest trial

Biotin fails to help MS in latest trial Published: 02 November 2020 A recent phase III trial has found that high-dose pharmaceutical-grade biotin (MD1003) does not improve disability or walking speed in people with progressive multiple sclerosis (MS).  This outcome disappointed researchers because an earlier trial had found that biotin,
Read More

Cancer drug rebuilds myelin in humans with MS

Cancer drug rebuilds myelin in humans with MS Published: 29 September 2020 A recent clinical trial of a cancer drug showed it repaired the myelin sheath that multiple sclerosis (MS) attacks, but the findings are bittersweet as the drug’s side effects are too serious for it to be used as
Read More